Doctor profile · Federal record
Dr. KATHERINE BRENNAN, MD
Cardiovascular Disease Physician (CMS: CARDIOVASCULAR DISEASE (CARDIOLOGY)) · LAFAYETTE, LA
- NPI 1497241020
- Accepts Medicare
- 8 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
441 HEYMANN BLVD
LAFAYETTE, LA 705032611
(337) 289-8429 - Additional location
-
330 Brookline Ave
Boston, MA 022155400
(617) 667-7000
Credentials & registration
- NPI registered
- July 2018 — 8 yrs on file
- Profile last updated
- October 2, 2024
- Year of graduation
- 2018 — 8 yrs since
- Specialty taxonomy
- 207RC0000X — NUCC code
- State license (1)
- Louisiana #343487
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1497241020. Last verified May 11, 2026.Open Payments
Industry payments received
All-time total
$111
Transactions
6
Manufacturers
3
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $63.96 | |
| PFIZER INC. | 1 | $29.78 | |
| Actelion Pharmaceuticals US, Inc. | 1 | $16.80 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
11
Patients
0
Total drug cost
$66
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Doxazosin Mesylate | Generic | 11 | 0 | $66 |